Ajitha Thanabalasuriar receives PATH award to advance lung disease research
Award from the Burroughs Wellcome Fund will open new avenues to preventing and treating pneumonia.
Global Health NOW: The Long, Strange Journey of Mycetoma Research; and Chicken Pox Parties Make a Comeback
A first-of-its-kind experimental hepatitis B drug might offer a ‘functional cure’ for some patients, per a study published yesterday in the New England Journal of Medicine; in two Chinese-led trials across 29 countries, ~1 in 5 patients given bepirovirsen (“bepi”) were able to stop treatment without showing signs of the liver virus. AP
Kenya has allocated zero funds to its NTDs project through 2029, leaving millions of Kenyans without structured protection from diseases such as kala-azar, schistosomiasis, lymphatic filariasis, and trachoma; last year, the program received 20 million KES (~$153,200) from national public health coffers. The Nation
1 in 6 patients with COVID-19 go on to develop long Covid—about 2X the rate estimated by U.S. health officials, per a Mass General Brigham study of almost 458,000 patients across 58 hospitals. JAMA Network Open IN FOCUS: GHN EXCLUSIVE Two women pass by the Mycetoma Research Center in Khartoum, Sudan, before its 2023 destruction during the country’s civil war. August 5, 2013. Ashraf Shazly. AFP via Getty The Long, Strange Journey of Mycetoma Research Early in 2024, Ahmed Fahal stood in the shattered shell of the Mycetoma Research Center in Khartoum, Sudan. The civil war between Sudan’s Armed Forces and the Rapid Support Forces erupted on April 15, 2023, and eventually spilled over into Fahal’s center, leaving it ransacked and looted.
- The reality overwhelmed Fahal, who has dedicated his career to researching the flesh-eating, bone-destroying neglected disease—and caring for its patients.
- “I could not keep my tears, my emotions, and I was really crying, actually, when I saw this,” says Fahal, who founded the center in 1991.
- In the “sky is the limit” days that followed, Fahal and colleagues anticipated greater recognition for the cruel disease, access to funders, new treatments and diagnostics, and new researchers coming to the field.
- DNDi will start a phase III trial of a new drug by the end of the year. Fosravuconazole needs to be taken once weekly for a year, instead of the current drug’s twice daily requirement.
- The field has drawn many more researchers: The Global Mycetoma Working Group now has 200+ members from 36 countries.
- Wendy van de Sande, at Erasmus University Medical Center in Rotterdam, and partners in Australia, the U.K., and Germany have screened nearly 10,000 existing drugs to find medications that could be effective against mycetoma.
READ THE FULL STORY BY BRIAN W. SIMPSON GLOBAL HEALTH VOICES VACCINES Chicken Pox Parties Make a Comeback Before the varicella vaccine, U.S. parents frequently turned to “chickenpox parties,” or planned exposure, to put some control around what was considered an inevitable infection. Since routine varicella vaccination began in the mid-1990s, U.S. chickenpox cases have dropped ~97%, with major declines in hospitalizations worldwide.
Yet the rise of vaccine hesitancy and influencers pushing “natural immunity” have led to a resurgence of chickenpox parties—much to the alarm of physicians.
- While childhood chickenpox cases are typically mild, the practice was not risk-free: Complications including pneumonia, meningitis, and brain inflammation still affected some children.
- “You didn't know which kids would get over it and be okay, and which kids would end up in the hospital,” said Jill Morgan with the University of Maryland School of Pharmacy.
By most standards, getting a 3–5-minute standing ovation would be a clear signifier of success—enough to make one blush. But at the Cannes Film Festival? It’s basically a slap in the face. There, any ovation worth its salt stretches well past the 10-minute mark. And critics are watching closely, explains Globe and Mail’s Barry Herz: “Is it sustained? Is it hearty? Is it boisterous?” Last week, the Spanish film The Black Ball brought the audience to its feet for an indulgent 20 minutes, Reuters reports. And since everyone’s on their feet, let’s throw in some ovations for global health. The polio vaccine alone deserves at least an hour. OPPORTUNITY QUICK HITS India's drug lifeline to Africa disrupted by Iran war – DW Under President Milei’s austerity, disabled Argentines risk losing essential services – AP Pleasure, Plague, and Panic: Why Cruise Ship Outbreaks Still Haunt Us – The MIT Press Reader Century-long analysis of biosafety incidents identifies strongest predictors of outbreaks, deaths – CIDRAP In Flint, Cash for Pregnant Women Leads to Better Outcomes for Babies – The New York Times (gift link) The largest undocumented disparity in maternal health – The Atlantic NSF puts new research grants to top universities on hold – Nature Should we reengineer the world's deadliest animal? – NPR’s The Short Wave Issue No. 2923
Global Health NOW is an initiative of Johns Hopkins Bloomberg School of Public Health.
Contributors include Brian W. Simpson, MPH, Dayna Kerecman Myers, Annalies Winny, Morgan Coulson, Kate Belz, Melissa Hartman, Jackie Powder, and Rin Swann. Write us: dkerecm1@jhu.edu, like us on Facebook and follow us on Instagram @globalhealth.now and X @GHN_News.
Please send the Global Health NOW free sign-up link to friends and colleagues: http://www.globalhealthnow.org/subscribe
Want to change how you receive these emails? You can update your preferences or unsubscribe from this list. -->
ABOUT
SUPPORT US
CONTACT US
Copyright 2026 Johns Hopkins Bloomberg School of Public Health. All Rights Reserved. Views and opinions expressed in Global Health NOW do not necessarily reflect those of the Johns Hopkins Bloomberg School of Public Health or Johns Hopkins University.
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
WHO chief calls for ceasefire amid DR Congo Ebola outbreak
Global Health NOW: Two Days, Two ‘Astonishing’ Temperatures; and Haitian Mothers Giving Birth in Hiding
Climate change is accelerating antibiotic resistance globally, per a first-of-its-kind international study published in the Lancet Planetary Health, which found that a 10% global increase in salmonella antibiotic resistance genes between 1940 and 2023 is associated with rising temperatures and altered precipitation patterns. The Guardian IN FOCUS A hot weather reminder on the big screen during the Sky Bet Championship play-off final at Wembley Stadium. London, May 23. John Walton/PA Images via Getty Two Days, Two ‘Astonishing’ Temperatures
The U.K. is experiencing record-breaking temperatures before summer has even started, sending hordes of Britons to pools and beaches and raising concerns about the march of extreme heat in a nation designed for cooler temperatures and where air conditioning can be scarce.
Forecasts show that the heat wave was set to make London hotter than Lagos this week, The Independent reports.
- U.K. officials issued the first amber health alert of 2026 last Friday. Then, temperatures in London reached nearly 95°F (34.8°C) Monday, a provisional record that was broken on Tuesday when they reached 95.2°F (35.1°C).
The soaring temperatures came on the heels of a May 20 report from the U.K.’s independent advisory committee on climate change, warning that the country’s climate adaptation plans thus far have been “inadequate.”
“Built for a climate that no longer exists”: The report warns that the country’s infrastructure is not prepared for hotter, longer, more frequent heat waves—leaving the country vulnerable to a range of climate-related risks:
- More than 9 in 10 U.K. homes are not insulated well enough to keep out the heat—and many are built to trap heat, exacerbating health problems, Inside Climate News reports.
- By 2050, the country should expect a daily water supply shortfall of 5 billion liters (shortages were already reported this week amid a surge in usage). By then, hotter heat waves could potentially cause overheating in over 90% of U.K. homes.
- Expanding access to air conditioning, shading, and other cooling measures, particularly in hospitals, care homes, and schools.
- Setting maximum temperature regulations for workplaces—both indoors and outside.
- Providing incentives to help low-income households install cooling technology.
359%
————
More dengue cases reported in the U.S. in 2024 than the annual average reported from 2010 through 2023, per the May 14 Morbidity and Mortality Weekly Report, which ties the jump almost entirely to international travel-acquired infections. —CIDRAP REPRODUCTIVE HEALTH RIGHTS Haitian Mothers Giving Birth in Hiding The Dominican Republic’s mass deportation campaign against Haitian migrants has increasingly led Haitian mothers to avoid hospitals for maternity care and deliveries, endangering them and their newborns. Crackdown at hospitals: Over the past year, Dominican authorities have stationed immigration officers at hospitals, where undocumented maternity patients are frequently detained shortly after delivery and deported back to Haiti and its ongoing humanitarian crisis.
- “It’s an affront to the human dignity of women. And their girls and boys,” said Cristiana Luis, leader of the advocacy group Movement of Dominican-Haitian Women.
Learn more about the Pulitzer Center’s U.S. Civil Society Microgrants call for proposals at an informational session today, Wednesday, May 27, at 1 p.m. EDT.
Selected projects will receive grants ranging from $2,000 to $4,000. Project proposals can support existing activities or support the launch of new activities.
- Register for today’s info session
- Learn about the full call for proposals
- Application deadline: Monday, June 8, 2026
Why the quarantine for hantavirus is so long – The Washington Post (gift link)
She Faced a Life-Threatening Miscarriage. Under Arkansas’ Abortion Ban, Even Calls to the Governor’s Office Didn’t Help. – ProPublica
They’ve Heard the Warnings. Gen Z Is Tanning Anyway. – The New York Times (gift link) Thanks for the tip, Kris Henry!
The peer coaching program getting men back on HIV/AIDS treatment in South Africa – Gates Foundation
Listen: The patients demanding unvaccinated blood transfusions – STAT
Tough peer-review process? Your paper might end up being more highly cited – Nature Issue No. 2922
Global Health NOW is an initiative of Johns Hopkins Bloomberg School of Public Health.
Contributors include Brian W. Simpson, MPH, Dayna Kerecman Myers, Annalies Winny, Morgan Coulson, Kate Belz, Melissa Hartman, Jackie Powder, and Rin Swann. Write us: dkerecm1@jhu.edu, like us on Facebook and follow us on Instagram @globalhealth.now and X @GHN_News.
Please send the Global Health NOW free sign-up link to friends and colleagues: http://www.globalhealthnow.org/subscribe
Want to change how you receive these emails? You can update your preferences or unsubscribe from this list. -->
ABOUT
SUPPORT US
CONTACT US
Copyright 2026 Johns Hopkins Bloomberg School of Public Health. All Rights Reserved. Views and opinions expressed in Global Health NOW do not necessarily reflect those of the Johns Hopkins Bloomberg School of Public Health or Johns Hopkins University.
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
Ebola outbreak in DR Congo collides with conflict and hunger, WHO warns
Blood proteins flag multiple sclerosis years before diagnosis, opening a window for prevention
A new study has revealed a group of blood proteins, that are altered in people who go on to develop multiple sclerosis (MS), in some cases more than a decade before diagnosis. The findings offer hope that a simple blood test could one day identify people at high risk of MS in time to act before damage occurs.
Global Health NOW: Distrust, Division, and Deficits in the Struggle to Contain Ebola; and WHO Confronts Defections
Hunger is increasingly used as a weapon of war, per analysis from Insecurity Insight, with 21,000+ documented incidents of “food-related violence” including strikes on food distribution systems and markets reported since 2018. The Guardian
Health care providers warn that easy access to GLP-1 weight loss drugs poses a threat to people with eating disorders; part of the treatment is aimed at helping people recognize natural hunger cues, which GLP-1s suppress. The Washington Post (gift link)
Misinformation about perimenopause on social media is prompting more women to seek hormonal therapy for menopause before they need it, and to cease hormonal contraception prematurely—upping their risk of unintended pregnancies, unnecessary medication, and missed diagnoses. Femtech World IN FOCUS A health worker wearing protective equipment crouches beside the coffin of a suspected Ebola victim outside a family home. Mongbwalu, Ituri Province, DRC, May 24. Michel Lunanga/Getty Distrust, Division, and Deficits in the Struggle to Contain Ebola
Health workers already struggling to mobilize a response to the Ebola outbreak in northeastern DRC now face further threats as years of division and disinformation fuel violence against health care facilities and workers, and lead infected patients to resist and flee care, reports Reuters via NBC News
- “There is denial of the disease within the population,” said Richard Lokodu, medical director of the Mongbwalu General Referral Hospital, which came under multiple attacks over the weekend, as assailants burned isolation tents and 18 Ebola patients fled. Medical facilities were also burned in Rwampara.
- Aid workers have also reported attacks as they seek to canvas the region spreading information and resources, reports the AP, as conspiracies run rampant. Funeral rites are a particular flashpoint as families seek to handle the bodies of those killed by the virus.
The Ebola outbreak will lead to devastating violence against women and girls – STAT (commentary)
People with Ebola pose little risk to public in US, experts say – CIDRAP GLOBAL HEALTH VOICES WORLD HEALTH ASSEMBLY WHO Confronts Defections Delegates at this year’s World Health Assembly avoided formally recognizing withdrawal attempts by both the U.S. and Argentina last week, in a quiet but firm effort to prevent a broader unraveling of the global health coalition, reports Health Policy Watch. Binding agreements: As member states test whether they can simply walk away, delegates are pointing to the binding conditions of the WHO Constitution, which includes no technical provision for member states to withdraw. The unpaid U.S. bill: The sole exception to this contract is the U.S., which stipulated its right to withdraw as a condition of joining the WHO in 1948—so long as all dues are settled.
- The U.S. still owes ~$280 million in outstanding dues, leading member states to vote to suspend U.S. voting rights by 2027, a signal that they still consider the U.S. bound by its obligations.
79th World Health Assembly (WHA79): Draft updated global action plan on antimicrobial resistance – IFPMA OPPORTUNITY QUICK HITS Misinformation is coming for the anti-HIV jab. Let’s get ahead of it – Bhekisisa
WHO chief says hantavirus 'situation is stable for now' – The Hill
Our warming planet is a petri dish for new and deadly microbes – The New Yorker
FDA staff blindsided by move allowing more e-cigarettes and nicotine pouches onto US market – AP
Firing Cancer Screening Experts Will Not Make Us Healthy Again – The New York Times (gift link) Thanks for the tip, Dave Cundiff!
Pap smears are designed to screen for cancer. Why are people afraid to get them? – The 19th
Why an Indian Village Leader’s Welfare Reels Are Going Viral – Reasons to Be Cheerful Issue No. 2921
Global Health NOW is an initiative of Johns Hopkins Bloomberg School of Public Health.
Contributors include Brian W. Simpson, MPH, Dayna Kerecman Myers, Annalies Winny, Morgan Coulson, Kate Belz, Melissa Hartman, Jackie Powder, and Rin Swann. Write us: dkerecm1@jhu.edu, like us on Facebook and follow us on Instagram @globalhealth.now and X @GHN_News.
Please send the Global Health NOW free sign-up link to friends and colleagues: http://www.globalhealthnow.org/subscribe
Want to change how you receive these emails? You can update your preferences or unsubscribe from this list. -->
ABOUT
SUPPORT US
CONTACT US
Copyright 2026 Johns Hopkins Bloomberg School of Public Health. All Rights Reserved. Views and opinions expressed in Global Health NOW do not necessarily reflect those of the Johns Hopkins Bloomberg School of Public Health or Johns Hopkins University.
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
International airlines urged to stick to safety measures in wake of Ebola outbreak
Ebola epidemic spreading rapidly and outpacing containment efforts
WHO chief calls for urgent Ebola action and pandemic preparedness
Ebola risk ‘very high’ in eastern DR Congo as UN intensifies response
Global Health NOW: The Race to Develop a New Ebola Vaccine; and Broadening HPV Vaccine Access to Boys
Heads up, readers! We won’t be publishing Monday in observance of Memorial Day in the U.S. We’ll be back Tuesday with more news!—The Editors IN FOCUS A border health officer at the Busunga crossing between Uganda and the Democratic Republic of Congo checks a traveler's temperature on May 18. Badru Katumba/AFP/Getty The Race to Develop a New Ebola Vaccine As the global health community mobilizes to respond to the Ebola outbreak centered in eastern DRC and Uganda that has now sickened ~600 ad killed ~139, a simultaneous effort is kicking into gear in labs worldwide: develop a vaccine for the Bundibugyo strain—fast. But such a vaccine is still months away, reports The Washington Post (gift link). The Bundibugyo strain has no approved vaccine or targeted treatment, and WHO officials say producing doses for trials could take six to nine months. Current status: There are two potential vaccine candidates, but neither is ready to move into human testing.
- The leading vaccine candidate uses the same platform as Merck’s Ervebo shot, which protects against the Zaire strain of Ebola. Previous research identified a Bundibugyo-specific version of that shot protected monkeys, but it was never manufactured to human-testing standards.
- A second candidate, built on technology similar to the AstraZeneca COVID-19 vaccine, could move into trials sooner, though there is not yet animal data to support safety and efficacy.
- Meanwhile, an investigational monoclonal antibody treatment, called MBP134 and developed by Mapp Biopharmaceutical Inc., can protect against multiple strains of Ebola and has been through early human testing.
- “In a time when hours matter, we’re delayed by weeks,” said Nicholas Enrich, the former top global health official for USAID.
- The campaign does not include boys, who can’t get routine HPV-related cancer screening through public health care.
- Experts say a gender-neutral HPV vaccination approach would improve overall cancer prevention.
The Changemaker Awards honor individuals leading collective action towards justice, equality, and peace in support of UN #SDGs. Successful changemakers demonstrate visionary leadership and the ability to make measurable, lasting impact within their communities and beyond—like Jîn Dawod (2025 Winner), a mental health visionary who transformed her experience as a Syrian refugee into life-changing support for displaced communities across 26 countries.
In 2026, the UN SDG Action Campaign will bring together nine finalists from all over the world for a unique program of coaching and capacity building in advance of the Heroes of Tomorrow: UN SDG Action Awards Ceremony, in Rome, Italy on October 29, 2026.
- Extended deadline: May 31, 2026
Global Health NOW is an initiative of Johns Hopkins Bloomberg School of Public Health.
Contributors include Brian W. Simpson, MPH, Dayna Kerecman Myers, Annalies Winny, Morgan Coulson, Kate Belz, Melissa Hartman, Jackie Powder, and Rin Swann. Write us: dkerecm1@jhu.edu, like us on Facebook and follow us on Instagram @globalhealth.now and X @GHN_News.
Please send the Global Health NOW free sign-up link to friends and colleagues: http://www.globalhealthnow.org/subscribe
Want to change how you receive these emails? You can update your preferences or unsubscribe from this list. -->
ABOUT
SUPPORT US
CONTACT US
Copyright 2026 Johns Hopkins Bloomberg School of Public Health. All Rights Reserved. Views and opinions expressed in Global Health NOW do not necessarily reflect those of the Johns Hopkins Bloomberg School of Public Health or Johns Hopkins University.
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
UN agencies step up Ebola response in eastern DR Congo
Global Health NOW: A ‘Once-in-a-Generation’ Reset for Humanitarian Aid; and Nicotine Pouch Popularity Surges
Iran’s appeal for support against attacks on healthcare by the U.S. and Israel failed at the WHA yesterday, with 19 votes in favor and 30 against; a similar resolution from Lebanon, which asks the WHO to provide support through medications and supplies, passed with 95 votes in favor and two against. Geneva Solutions Over half of U.S. teens are unaware of their right to independently access STI testing and treatment without a guardian’s consent, finds a new study published today by the American Academy of Pediatrics. CIDRAP Undiagnosed ADHD may be linked to traffic-related injuries among adults, finds a new study presented at the American Psychiatric Association annual meeting; the study found that ~35% of 95 adults admitted to the hospital for traffic-related injuries screened positive on the Adult ADHD Self-Report Scale and that high-risk driving behaviors were more common among adults who screened positive. MedPage Today Thanks for the tip, Chiara Jaffe! IN FOCUS Residents gather to collect drinking water in the Rimal neighborhood of Gaza City on May 19. Ahmed Al Arini / Middle East Images / AFP via Getty A ‘Once-in-a-Generation’ Reset for Humanitarian Aid The global humanitarian aid system is “no longer fit for purpose,” warns a major commission in a landmark report that calls for a total overhaul of aid systems rather than incremental reforms, reports the Middle East Eye. Background: A rising number of conflict-driven deaths and forced displacement globally spurred the 2024 launch of the CHH-Lancet Commission on Health, Conflict and Forced Displacement—a collaboration between the Johns Hopkins Center for Humanitarian Health and The Lancet.
- Their research period spanned the Trump administration’s dismantling of USAID and other international funding shortfalls—demonstrating the politicization of aid that essentially functions as “rationing by design” driven by donor interests rather than human need.
- Rising harm: Conflict deaths nearly doubled between 2021 and 2024, and attacks on healthcare hit a record 3,663 incidents in 2024.
- Need gaps: 239 million people are expected to need aid in 2026, but only ~87 million are likely to receive it.
- Moving decision-making and funding control to affected communities.
- Financing to create pooled, independent funds that are channeled straight to local groups and healthcare and are insulated from donor politics.
- Using health outcomes to create better accountability around violations of humanitarian law.
- A single streamlined UN aid agency instead of fragmented groups.
- Sales topped 23 billion+ units in 2024—a 50% spike over the previous year—creating a ~$7 billion industry in 2025.
- The regulatory debate is playing out across Europe, reports Politico—with Sweden taking a more permissive approach and France instituting a total ban.
Global Health NOW is an initiative of Johns Hopkins Bloomberg School of Public Health.
Contributors include Brian W. Simpson, MPH, Dayna Kerecman Myers, Annalies Winny, Morgan Coulson, Kate Belz, Melissa Hartman, Jackie Powder, and Rin Swann. Write us: dkerecm1@jhu.edu, like us on Facebook and follow us on Instagram @globalhealth.now and X @GHN_News.
Please send the Global Health NOW free sign-up link to friends and colleagues: http://www.globalhealthnow.org/subscribe
Want to change how you receive these emails? You can update your preferences or unsubscribe from this list. -->
ABOUT
SUPPORT US
CONTACT US
Copyright 2026 Johns Hopkins Bloomberg School of Public Health. All Rights Reserved. Views and opinions expressed in Global Health NOW do not necessarily reflect those of the Johns Hopkins Bloomberg School of Public Health or Johns Hopkins University.
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
Ebola outbreak: ‘Every epidemic begins in a community and ends in a community’
Flak jackets and final goodbyes: Lebanon’s first responders under fire
Ebola risk is high inside DR Congo but it’s no pandemic emergency: WHO
‘Jumping gene’ helps explain elevated pancreatic cancer risk in French-Canadians
Researchers at McGill University have discovered a centuries-old genetic mutation that helps to explain why some French‑Canadians in Quebec are at an elevated risk of pancreatic cancer. Until quite recently, standard genetic tests have not been able to identify this “jumping gene” cause.
The findings, published in the Journal of Medical Genetics, suggest better-targeted genetic testing could help identify people at higher cancer risk who were previously missed.
Global Health NOW: Ebola Worries Loom Over #WHA79; and How AI is Accelerating Biosecurity Risks
- “From conflicts to economic crises to climate change and aid cuts, we live in difficult, dangerous and divisive times,” WHO Director-General Tedros Adhanom Ghebreyesus said yesterday at the WHA's opening, per Health Policy Watch.
- The outbreak has caused 131 suspected deaths and 513 suspected cases, according to DRC health minister Samuel-Roger Kamba, per The New York Times (gift link).
- 30 cases have been laboratory confirmed and linked to the outbreak in the DRC’s northeastern Ituri Province.
- 2 cases have been confirmed in Uganda.
- Tedros said today that he is “deeply concerned about the scale and speed” of the outbreak, Reuters reports. He expects numbers to increase as surveillance, contact tracing, and lab testing scale up.
- The WHO's Emergency Committee is convening today to discuss the outbreak.
- “We are witnessing the end of an era, and we must have the courage to build the next one,” Ghana’s President John Dramani Mahama said yesterday, noting that global health cuts could lead to 9 million preventable deaths by 2030, the Ghanian Times reports. His own country has lost $78 million in USAID funds, affecting programs in malaria, maternal and child health, HIV, and nutrition.
- Spain’s Prime Minister Pedro Sánchez called for greater investment in global health in the face of “the pandemic of egotism and selfishness,” Health Policy Watch reports. Spain has boosted its official development aid by 30%, he said. Sánchez obliquely castigated the U.S., saying “the country that cut $18 billion from global public health and ODA [official development assistance] has spent more than $29 billion on war.”
US bans travellers from DRC, Uganda and South Sudan amid major Ebola outbreak – The Telegraph Your guide to events at the 79th World Health Assembly – WHA Guide 2026 Watch the World Health Assembly sessions – WHO GLOBAL HEALTH VOICES HEALTH SECURITY How AI is Accelerating Biosecurity Risks Advanced biological AI tools are powering a research revolution, allowing scientists to design proteins and viruses—and opening up access to bioengineering knowledge and tools to people outside of labs. Promise and risk: This new era could pave the way to great medical discoveries—and, scientists fear, for bad actors to misuse in the creation of toxins, viruses, and other bioweapons that can evade detection. A range of responses: Scientists say a series of safeguards are needed in response to increased risks, including better screening by companies that synthesize nucleic acids to order so they can better identify dangerous sequences.
- Others say AI tools themselves must have more stringent access controls and flagging systems to prevent misuse.
Global Health NOW is an initiative of Johns Hopkins Bloomberg School of Public Health.
Contributors include Brian W. Simpson, MPH, Dayna Kerecman Myers, Annalies Winny, Morgan Coulson, Kate Belz, Melissa Hartman, Jackie Powder, and Rin Swann. Write us: dkerecm1@jhu.edu, like us on Facebook and follow us on Instagram @globalhealth.now and X @GHN_News.
Please send the Global Health NOW free sign-up link to friends and colleagues: http://www.globalhealthnow.org/subscribe
Want to change how you receive these emails? You can update your preferences or unsubscribe from this list. -->
ABOUT
SUPPORT US
CONTACT US
Copyright 2026 Johns Hopkins Bloomberg School of Public Health. All Rights Reserved. Views and opinions expressed in Global Health NOW do not necessarily reflect those of the Johns Hopkins Bloomberg School of Public Health or Johns Hopkins University.
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
